The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men
- PMID: 37622539
- PMCID: PMC10843753
- DOI: 10.1002/alz.13407
The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men
Abstract
Introduction: Despite their increased application, the heritability of Alzheimer's disease (AD)-related blood-based biomarkers remains unexplored.
Methods: Plasma amyloid beta 40 (Aβ40), Aβ42, the Aβ42/40 ratio, total tau (t-tau), and neurofilament light (NfL) data came from 1035 men 60 to 73 years of age (μ = 67.0, SD = 2.6). Twin models were used to calculate heritability and the genetic and environmental correlations between them.
Results: Additive genetics explained 44% to 52% of Aβ42, Aβ40, t-tau, and NfL. The Aβ42/40 ratio was not heritable. Aβ40 and Aβ42 were genetically near identical (rg = 0.94). Both Aβ40 and Aβ42 were genetically correlated with NfL (rg = 0.35 to 0.38), but genetically unrelated to t-tau.
Discussion: Except for Aβ42/40, plasma biomarkers are heritable. Aβ40 and Aβ42 share mostly the same genetic influences, whereas genetic influences on plasma t-tau and NfL are largely unique in early old-age men. The absence of genetic associations between the Aβs and t-tau is not consistent with the amyloid cascade hypothesis.
Keywords: Aβ40; Aβ42; Aβ42/40 ratio; gene; heritability; neurofilament light (NfL); plasma biomarkers; total tau (t-tau); twin.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors have no conflict of interest to report. Author disclosures are available in the supporting information.
Figures


References
-
- 2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020. - PubMed
-
- Daviglus ML, Bell CC, Berrettini W, et al. In NIH Consensus Statement Science Statements. National Institutes of Health State‐of‐the‐Science Conference statement: Preventing Alzherimer's disease and cognitive decline; 2010:1‐27. - PubMed
-
- Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270‐279. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials